LEGN 40.14 (+4.53%)
US52490G1022BiotechnologyBiotechnology

Legend Biotech (LEGN) Stock Highlights

40.14 | +4.53%
2024-11-21 01:12:55
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firms lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from North America.

Statistics

Range Today
38.41 41
Volume Today 2.23M
Range 1 Year
36.92 70.13
Volume 1 Year 279.92M
Range 3 Year
30.75 77.32
Volume 3 Year 635.78M
Range 10 Year
23.41 77.32
Volume 10 Year 778.05M

Highlights

Market Capitalization 7.55B (mid)
Floating Shares 162.55M
Current Price 40.14
Price To Earnings -26.37
Price To Revenue 30.81
Price To Book 6.33
Earnings Per Share -1.54
Payout Ratio 0%

Performance

Latest +4.53%
1 Month -5.84%
3 Months -28.98%
6 Months -11.62%
1 Year -37.32%
3 Years -27.6%
5 Years +8.46%
10 Years +8.46%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.